Pop Test Cortisol LLC
Pop Test Cortisol acquires chemotherapy sensitizer Org34517 from Merck & Co. Breast Cancer growth slowed and reversed
Pop Test Cortisol LLC is a research and development company focusing on the development of a drug called ORG34517 that was acquired from Merck in 2010. It is the company’s intent to provide clinical proof of concept in key oncology indications and possibly selected CNS indications and then to sell the company to a 3rd party for further development and commercialization.
Org34517 is one of a new class of therapeutic agents designe